Evidence map›Paper›PMID 40408350›Full record

ArticlePloS one2025

Social prescribing to improve health and well-being of patients presenting with non-medical health related social needs in primary care: Study protocol of a multi-center randomized controlled pragmatic feasibility trial.

Hendrik Napierala, Niklas Jeske, Stephanie Roll, Juliane Köberlein-Neu, Wolfram J Herrmann

Abstract readClinical Trial Protocol
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Hendrik NapieralaInstitute of General Practice and Family Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Niklas JeskeInstitute of General Practice and Family Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Stephanie RollInstitute of Social Medicine, Epidemiology and Health Economics, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Juliane Köberlein-NeuSchumpeter School of Business and Economics, Bergische Universität Wuppertal, Wuppertal, Germany.
Wolfram J HerrmannInstitute of General Practice and Family Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany.ORCID https://orcid.org/0000-0002-9505-4911

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNon-medical health related social problems are highly prevalent in primary care. Even though there is a wide range of non-clinical support and services available in German communities, which can potentially meet the needs of the affected patients, there are no formalized connections between these services and primary care. One potential solution is social prescribing (SP) providing general practitioners (GPs) with a non-medical referral option, which can accompany existing treatments to improve health and well-being. The goal of this trial is to test the feasibility of a randomized controlled trial and potential benefit of SP in the primary care setting in Germany.

methodsThis trial is designed as a multi-center, two-armed, open, exploratory, individually randomized (2:1) controlled, pragmatic, feasibility trial. 300 adult patients presenting with one or more non-medical health-related social needs will be recruited in GP practices in Berlin and Brandenburg, Germany. Participants in the intervention group will receive a referral to a link worker. The link worker assesses the social needs, agrees on a goal and sets up an action plan together with the patient. The link worker then connects the patient to suitable non-clinical support and services in the community (e.g., volunteering opportunities). The GP is informed about the actions taken through a feedback form. Participants in the control group will receive treatment-as-usual plus a brochure with information about local offers of non-clinical support and services in the community. Follow-up per patient is 6 months with measurements at 3 and 6 months. Primary endpoint is the feasibility of the trial measured by (1) proportion of participants who have at least one appointment with the link worker (intervention arm only), (2) proportion of participants that drop out of the trial before the 6-month follow-up (both arms). Secondary endpoints include further feasibility endpoints (acceptability, practicality, demand), clinical endpoints such the health status and wellbeing, and a goal-based outcome for the intervention group. The trial is accompanied by a process evaluation, including qualitative episodic interviews with patients and stakeholders. Furthermore, a description of selected economic consequences of SP and its intervention costs will be conducted. DISCUSSION: This trial will assess the feasibility of implementing SP in the German primary care setting and will provide information and data necessary to plan a confirmatory trial. Implementing SP could be an adequate solution to address psychosocial problems in primary care.

trial registrationGerman Clinical Trials Registry, DRKS-ID: DRKS00034654. Registered on August 27th.2024. https://drks.de/search/en/trial/DRKS00034654.

Indexed as

Primary Health CareSocial PrescribingAdultFeasibility StudiesFemaleGeneral PractitionersGermanyHumansMaleMiddle AgedMulticenter Studies as TopicPragmatic Clinical Trials as TopicRandomized Controlled Trials as TopicReferral and Consultation

Identifiers

PMID40408350
PMCPMC12101629

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.